Bioporto A/S logo

BIOPOR - Bioporto A/S News Story

DKK4.42 0.0  0.0%

Last Trade - 05/05/21

Sector
Industrials
Size
Small Cap
Market Cap £137.7m
Enterprise Value £126.4m
Revenue £2.70m
Position in Universe 826th / 1836

Increase in share capital following exercise of warrants – Notice of changes in share capital and voting rights pursuant to section 32 of the Danish Capital Markets Act

Thu 8th April, 2021 8:16am
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210408:nGNE66qDVS&default-theme=true


April 8, 2021
Announcement no. 6

Increase in share capital following exercise of warrants – Notice of changes
in share capital and voting rights pursuant to section 32 of the Danish
Capital Markets Act

The Company’s share capital has been increased by normally DKK 1,172,500,
corresponding to 1,172,500 new shares, as a result of exercise of warrants
issued under the Company’s incentive warrant program. Total proceeds from
the capital increase amount to approximately DKK 4.4 million.
The new shares have rights to dividends and other rights in the Company as
from 8 April 2021. The new shares will be listed on Nasdaq Copenhagen,
expectedly with first day of trading on 12 April 2021.

After the share capital increase, the Company’s share capital amounts to
nominally DKK 267,754,404 divided into 267,754,404 shares each carrying 1
voting right, corresponding to a total of 267,754,404 voting rights, cf.
section 32 of the Danish Capital Markets Act.

Amended Articles of Association reflecting the above are available on the
Company’s website.

For further information, please contact:

Ole Larsen, CFO

Telephone +45 4529 0000, e-mail: investor@bioporto.com

About BioPorto

BioPorto is an in vitro diagnostics company that provides tests and antibodies
to clinicians and researchers around the world. We use our antibody and assay
expertise to transform novel research tools into clinically actionable
biomarkers that can make a difference in patients’ lives. BioPorto is
headquartered in Hellerup, Denmark and is listed on the NASDAQ Copenhagen
stock exchange  CPH:BIOPOR .


Attachment
*     2021 04 08 - Announcement no. 6
(https://ml-eu.globenewswire.com/Resource/Download/da54565c-0eaa-46bf-9833-b7db220278ef)
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.